Research Article
Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study
Table 3
Multiple regression analysis for total inpatient costs.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
R-square = 0.5780 and adjusted R-square = 0.5779 in a multiple linear regression model that was adjusted for length of stay, age, sex, insurance type, hospital type, region, hypertension, coronary heart disease, diabetes, chronic pulmonary disease, peripheral vascular disease, other neurological diseases, rheumatoid arthritis, and peptic ulcer disease. The baseline represents the inpatient cost for a female who did not use any TCM with Urban Resident Basic Medical Insurance admitted to a primary hospital and non-TCM hospital in the western region without the above-observed comorbidities. TCM: traditional Chinese medicine; UEBMI: Urban Employee Basic Medical Insurance scheme; URBMI: Urban Resident Basic Medical Insurance scheme. |